The findings of our study demonstrated for the first time that Prevotellaceae abundance influenced the efficacy of CRC anti-PD-L1 immunotherapy, confirming that a high abundance of Prevotellaceae enhanced the efficacy of anti-PD-L1 tumor therapy. The gene discussed is CD274; the disease is colorectal carcinoma.